Brand-Ad-30-6
 IADVL
Indexed with PubMed and Science Citation Index (E) 
 
Users online: 2017 
     Home | Feedback | Login 
About Current Issue Archive Ahead of print Search Instructions Online Submission Subscribe What's New Contact  
  NAVIGATE Here 
    Next article
    Previous article
    Table of Contents

 RESOURCE Links
    Similar in PUBMED
    Search Pubmed for
    Search in Google Scholar for
    Citation Manager
    Access Statistics
    Reader Comments
    Email Alert *
    Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed1006    
    Printed23    
    Emailed1    
    PDF Downloaded0    
    Comments [Add]    
    Cited by others 1    

Recommend this journal

 

 
Year : 1991  |  Volume : 57  |  Issue : 2  |  Page : 96--97

Further Evaluation of Therapeutic Efficacy of Dapsone in Cutaneous Leishmaniasis



Correspondence Address:
K K Singh


Login to access the Email id

Source of Support: None, Conflict of Interest: None


Rights and PermissionsRights and Permissions

Thirty four patients of cutaneous Leishmaniasis had received dapsone as treatment. The dose was approximately 2 mg per kilogram body weight per day. The duration of the treatment ranged from 14 to 63 days with the mean of 31.18 days. Twenty two patients (64.70%) had shown complete healing. Four patients (11.76%) did not show any response. Ulcerative variety (95.23%) responded fully, whereas nodular variety (15.38%) had poor response. No recurrence was seen during a follow up examination of 9 months.






[PDF Not available]*


        
Print this article     Email this article

Online since 15th March '04
Published by Wolters Kluwer - Medknow